Lei Ding

Senior Scientist at IN8bio
  • Claim this Profile
Contact Information
Location
Birmingham, Alabama, United States, US

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Senior Scientist
      • Feb 2023 - Present

    • Staff Scientist II
      • Feb 2020 - Feb 2023

    • Scientist I
      • Jan 2019 - Feb 2020

      ▪ Continued optimization for long-term gene correction of sickle cell mutation in human patient derived hematopoietic stem cells for pre-FDA clinical trial application ▪ Continued engineering and optimization of modified Cas9 proteins for better fidelity and safety

    • Postdoctoral Researcher
      • Dec 2012 - Dec 2018

      ▪ Designed and developed a novel modified CRISPR/Cas9 genome editing technology that greatly improve cell viability and reduce on-target and off-target INDELs, US/International patent WO2016205703A1 & WO2016205680A1 filed. ▪ Purified wild type Cas9 and over a 20 modified version of Cas9 recombinant proteins for RNP delivery in genome editing experiments. ▪ Successfully performed CRISPR/Cas9 enhanced gene correction of sickle cell disease(SCD) mutation in human sickle patient… Show more ▪ Designed and developed a novel modified CRISPR/Cas9 genome editing technology that greatly improve cell viability and reduce on-target and off-target INDELs, US/International patent WO2016205703A1 & WO2016205680A1 filed. ▪ Purified wild type Cas9 and over a 20 modified version of Cas9 recombinant proteins for RNP delivery in genome editing experiments. ▪ Successfully performed CRISPR/Cas9 enhanced gene correction of sickle cell disease(SCD) mutation in human sickle patient derived iPSCs and human/mouse sickle hematopoietic stem cells with high efficacy. Anayzed the short-term and long-term outcome of the genome editing using digital droplet PCR(ddPCR), sanger sequencing and next-generation sequencing technologies. ▪ Cured a humanized SCD mouse model by transplanting corrected hematopoietic stem cells using modified CRISPR/Cas9 system. 2nd and 3rd serial transplantation vaditated (First-in-the -world, unpublished data). ▪ Successfully purified a list of recombinant proteins and human/mouse cytokines for stem cell expansion and function study including bFGF, IL-6, c-Myc, TLR-9, etc.

    • Graduate Research Assistant
      • Dec 2007 - Nov 2012

      Ph.D student research in structural and molecular basis of nucleic acid binding proteins and their specific interactions with RNA/DNA molecules

Education

  • University of Alabama at Birmingham
    Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Genetics
    2007 - 2012
  • Wuhan University
    Bachelor of Science - BS, Biotechnology
    1999 - 2003

Community

You need to have a working account to view this content. Click here to join now